The Portuguese Institute of Oncology (IPO) of Coimbra received the highest distinction in heart health protection. This certification recognizes the institution's work in preserving the cardiovascular health of cancer patients during treatments.
The distinction is particularly relevant because cancer patients are naturally focused on fighting cancer, and may not be aware that some cancer treatments can affect heart health.
IPO Coimbra thus demonstrates its commitment to providing oncological care that does not compromise the long-term quality of life of its patients, ensuring an integrated approach that protects both the effectiveness of cancer treatment and cardiovascular health.
This certification represents a recognition of the implementation of protocols and practices that monitor and protect the heart throughout the entire cancer treatment process at the institute.




